Reading Time: 6 minutes
Comprehensive Psychiatric Evaluation: Annotated Structure Walkthrough
| What this is
This is a structural and reasoning reference, not a completed case study. It shows how each section of the Week 8 Comprehensive Psychiatric Evaluation is organized and the clinical logic behind it, illustrated with short generic fragments — not a full patient case you could submit. Use it to understand the reasoning pattern, then build your own evaluation from your assigned case data. |
How to Use This Walkthrough
Each section below shows three things: what content belongs in that section, a short illustrative fragment showing the expected tone and level of clinical specificity, and a reasoning note explaining why that section is structured the way it is. The fragments are intentionally partial and generic — they model phrasing and reasoning, not a complete evaluation.
Section-by-Section Walkthrough
| 1. History of Present Illness (HPI)
Onset, duration, course, precipitating factors, and pertinent negatives, told in clinical rather than narrative style.
Why this works Note the pertinent negative at the end. Stating what was specifically ruled out (no SI, no mania) does two things at once: it documents safety screening and it pre-narrows your differential before you even reach that section. |
| 2. Mental Status Exam (MSE)
Direct clinical observation at the time of the encounter, covering appearance through judgment, in standard order.
Why this works This is observed status, not patient-reported history — that distinction is what separates the MSE from the HPI. Each line is a clinical term plus a brief qualifier, not a restated symptom from the patient’s narrative. Structured documentation in this format is associated with improved diagnostic accuracy (Norris & Clark, 2024). |
| 3. Differential Diagnosis
A minimum of three plausible diagnoses, each addressed explicitly — including the ones ruled out — with the specific criteria that support or argue against each.
Why this works Notice the diagnosis isn’t just named and dismissed — a specific DSM-5-TR criterion (duration) is the stated reason for ruling it out, and a genuine remaining uncertainty is flagged rather than glossed over. That’s the difference between reasoning and listing, and it matters clinically because overlapping symptom presentations across mood and trauma-related disorders are a well-documented source of misdiagnosis (Demartini et al., 2023). |
| 4. Diagnostic Formulation and Justification
The primary diagnosis, mapped explicitly to the DSM-5-TR criteria the case data satisfies.
Why this works Each clinical detail from the case is tied to a specific numbered criterion rather than a general description of the disorder. This is what graders mean by ‘showing your reasoning’ rather than stating a conclusion, and it follows the symptom-count threshold structure used in the DSM-5-TR itself (American Psychiatric Association, 2022; Bains & Abdijadid, 2023). |
| 5. Psychometric / Rating Scale Selection
Identification of an appropriate screening tool, with justification tied to the tool’s validated population and what it measures.
Why this works The justification names the validated population (adults), the setting it’s normed for, and a practical reason it fits this case (repeatable for monitoring) — not just the tool’s name. This level of specificity reflects the tool’s actual evidence base for adult screening and severity tracking (Lee et al., 2023). |
| 6. Psychopharmacological and Treatment Plan
Recommendations tied explicitly back to the diagnosis and patient-specific factors such as age, comorbidities, and prior treatment history.
Why this works The reasoning is explicitly conditional on case-specific facts (no prior trial, no cardiac contraindication) rather than stating a default protocol that would apply to any patient with this diagnosis — consistent with guidance that antidepressant selection should be individualized rather than uniform across patients with the same diagnosis (Fugger et al., 2022; Kwong et al., 2022). |
| 7. Ethical and Legal Considerations
At least one consideration specific to the case context, not a generic statement about confidentiality or informed consent in general.
Why this works The ethical point is anchored to something specific the patient said, rather than a boilerplate informed-consent statement that could apply to any psychiatric encounter. |
Reasoning Checklist Before You Submit
- Does every differential diagnosis you list get an explicit reason for inclusion or exclusion?
- Does your diagnostic formulation cite specific DSM-5-TR criteria, not just a general disorder description?
- Does your MSE describe what you observed, with no restated HPI content?
- Does your treatment plan reference at least one patient-specific factor from the case, not a generic protocol?
- Are your references peer-reviewed and within 5 years, with DSM-5-TR cited as the current edition?
Related Resources
See the companion guide page for the full rubric breakdown, common point-loss patterns, and FAQ on grading expectations for this assignment.
References
American Psychiatric Association. (2022). Diagnostic and statistical manual of mental disorders (5th ed., text rev.).
Bains, N., & Abdijadid, S. (2023). Major depressive disorder. In StatPearls. StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK559078/
Demartini, B., Goeta, D., Marchetti, M., Bertino, V., Mazzucchelli, C., Cocchi, S., Olgiati, P., Aguglia, A., & Gambini, O. (2023). Digital phenotyping for differential diagnosis of major depressive episode: Narrative review. JMIR Mental Health, 10, e37225. https://doi.org/10.2196/37225
Fugger, G., Bartova, L., Fabbri, C., Fanelli, G., Dold, M., Swoboda, M. M. M., Kautzky, A., Zohar, J., Souery, D., Mendlewicz, J., Montgomery, S., Rujescu, D., Serretti, A., & Kasper, S. (2022). The sociodemographic and clinical profile of patients with major depressive disorder receiving SSRIs as first-line antidepressant treatment in European countries. European Archives of Psychiatry and Clinical Neuroscience, 272, 1029–1041. https://doi.org/10.1007/s00406-021-01368-3
Kwong, J., Chouinard, M.-C., & Dionne, C. E. (2022). Individualized antidepressant therapy in patients with major depressive disorder: Novel evidence-informed decision support tool. Canadian Family Physician, 68(11), 807–814. https://doi.org/10.46747/cfp.6811807
Lee, T., Patel, R., & Osei, A. (2023). Implementing the Patient Health Questionnaire-9 (PHQ-9) to identify and refer adults with depression. International Journal of Depression and Anxiety, 6(1), 040. https://clinmedjournals.org/articles/ijda/international-journal-of-depression-and-anxiety-ijda-6-040.php
Norris, D., & Clark, M. S. (2024). Mental status examination. In StatPearls. StatPearls Publishing. https://www.statpearls.com/nurse/ce/activity/102804
The post Comprehensive Psychiatric Evaluation: Annotated Structure Walkthrough appeared first on Your Online Resourses Guide.